Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,otherLiab,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,capitalSurplus,retainedEarnings,goodWill,treasuryStock,otherStockholderEquity,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,esgPopulated,tradeable,exchangeDataDelayedBy,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,epsForward,epsCurrentYear,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,exchange,marketState,market,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry
t0,KDSKF,3826000000.0,174786000,,,256000000,79000000,504000000,,2244000000,303000000,303000000,1781500000,-34000000,,,,45000000,2244000000,1941000000,0,-47000000,294000000,211000000,502000000,4690000000.0,6500000000.0,8516000000.0,722000000.0,15095000000.0,8516000000.0,120000000.0,1182000000.0,359000000.0,1640000000.0,2329000000.0,224000000.0,135000000.0,3754000000.0,5811000000.0,481000000.0,215000000.0,1741000000.0,2989000000.0,2095000000.0,1448000000.0,,,,,,-86000000,0,494500000,-263500000,-395000000,-130000000,9000000,384500000,-60000000,-4500000,289500000,159500000,76000000,-94500000,14000000,-244000000,-118000000,3482000000.0,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,54.737,0.35141885,155.76 - 219.0,-8.503006,-0.03882651,155.76,219.0,1598572800,2.4,61.013622,0.011295787,3.45,6.63,5.12,-0.92795056,210.497 - 213.5,212.4686,0.0,0.0,0,0,finmb_410412,Other OTC,Koninklijke DSM N.V.,EUR,639,214,41.112694,42.963,205.12172,5.3752747,0.026205292,186.0166,24.480392,0.13160327,36793610240,31.749168,4.8994946,15,America/New_York,EDT,-14400000,2,PNK,PRE,us_market,KONINKLIJKE DSM NV,210.497,1630510799,-1.9716034,213.5,213.5,210.497,24294,0.55,,,219.0,155.76,205.12,186.02,639,214,174.79M,,172.26M,0.22%,56.58%,,,,,,2.9,1.34%,2.40,1.13%,,65.50%,"Aug 27, 2020","Aug 04, 2021",,,"Dec 30, 2020","Jun 29, 2021",14.61%,9.45%,3.37%,8.00%,8.53B,49.52,,2.78B,1.37B,630M,3.45,,1.86B,10.75,3.12B,36.35,2.49,42.96,1.49B,418.38M,Value,6411 TE,Basic Materials,21173,1,3,"Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, human milk oligosaccharides, and vitamins, as well as premix, market-ready solutions, and personalized nutrition; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty food enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; and Dyneema, a fiber solution for use in ropes and lines, and outdoor and sports applications. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides yeast and enzymes for the conversion of starch, corn fiber, and biomass. Koninklijke DSM N.V. has a strategic partnership with Mile High Labs, LLC to develop and commercialize science-backed cannabinoid consumer products. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.",Heerlen,6,1609372800,1625097600,2,Netherlands,http://www.dsm.com,86400,1,Het Overloon 1,Specialty Chemicals
t-1,KDSKF,3826000000.0,174786000,,,256000000,79000000,504000000,,2244000000,303000000,303000000,1781500000,-34000000,,,,45000000,2244000000,1941000000,0,-47000000,294000000,211000000,502000000,4690000000.0,6500000000.0,8516000000.0,722000000.0,15095000000.0,8516000000.0,120000000.0,1182000000.0,359000000.0,1640000000.0,2329000000.0,224000000.0,135000000.0,3754000000.0,5811000000.0,481000000.0,215000000.0,1741000000.0,2989000000.0,2095000000.0,1448000000.0,,,,,,-86000000,0,494500000,-263500000,-395000000,-130000000,9000000,384500000,-60000000,-4500000,289500000,159500000,76000000,-94500000,14000000,-244000000,-118000000,3482000000.0,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,54.737,0.35141885,155.76 - 219.0,-8.503006,-0.03882651,155.76,219.0,1598572800,2.4,61.013622,0.011295787,3.45,6.63,5.12,-0.92795056,210.497 - 213.5,212.4686,0.0,0.0,0,0,finmb_410412,Other OTC,Koninklijke DSM N.V.,EUR,639,214,41.112694,42.963,205.12172,5.3752747,0.026205292,186.0166,24.480392,0.13160327,36793610240,31.749168,4.8994946,15,America/New_York,EDT,-14400000,2,PNK,PRE,us_market,KONINKLIJKE DSM NV,210.497,1630510799,-1.9716034,213.5,213.5,210.497,24294,0.55,,,219.0,155.76,205.12,186.02,639,214,174.79M,,172.26M,0.22%,56.58%,,,,,,2.9,1.34%,2.40,1.13%,,65.50%,"Aug 27, 2020","Aug 04, 2021",,,"Dec 30, 2020","Jun 29, 2021",14.61%,9.45%,3.37%,8.00%,8.53B,49.52,,2.78B,1.37B,630M,3.45,,1.86B,10.75,3.12B,36.35,2.49,42.96,1.49B,418.38M,Value,6411 TE,Basic Materials,21173,1,3,"Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, human milk oligosaccharides, and vitamins, as well as premix, market-ready solutions, and personalized nutrition; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty food enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; and Dyneema, a fiber solution for use in ropes and lines, and outdoor and sports applications. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides yeast and enzymes for the conversion of starch, corn fiber, and biomass. Koninklijke DSM N.V. has a strategic partnership with Mile High Labs, LLC to develop and commercialize science-backed cannabinoid consumer products. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.",Heerlen,6,1609372800,1625097600,2,Netherlands,http://www.dsm.com,86400,1,Het Overloon 1,Specialty Chemicals
t-2,KDSKF,2944000000.0,174786000,,,67000000,88000000,56000000,,2080000000,208000000,208000000,1701000000,-15000000,,,,17000000,2080000000,1872000000,0,-141000000,4000000,50000000,55000000,1940000000.0,6877000000.0,7399000000.0,555000000.0,14364000000.0,338000000.0,1149000000.0,1134000000.0,389000000.0,871000000.0,2264000000.0,239000000.0,7000000.0,3774000000.0,5425000000.0,321000000.0,43000000.0,1483000000.0,3311000000.0,1879000000.0,1207000000.0,489000000.0,7791000000.0,2515000000.0,-1219000000.0,-243000000.0,-3000000,0,-996000000,-239000000,-320000000,25000000,15000000,-815000000,-60000000,-45000000,504000000,171000000,6000000,-94500000,-96000000,252000000,-211000000,3161000000.0,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,54.737,0.35141885,155.76 - 219.0,-8.503006,-0.03882651,155.76,219.0,1598572800,2.4,61.013622,0.011295787,3.45,6.63,5.12,-0.92795056,210.497 - 213.5,212.4686,0.0,0.0,0,0,finmb_410412,Other OTC,Koninklijke DSM N.V.,EUR,639,214,41.112694,42.963,205.12172,5.3752747,0.026205292,186.0166,24.480392,0.13160327,36793610240,31.749168,4.8994946,15,America/New_York,EDT,-14400000,2,PNK,PRE,us_market,KONINKLIJKE DSM NV,210.497,1630510799,-1.9716034,213.5,213.5,210.497,24294,0.55,,,219.0,155.76,205.12,186.02,639,214,174.79M,,172.26M,0.22%,56.58%,,,,,,2.9,1.34%,2.40,1.13%,,65.50%,"Aug 27, 2020","Aug 04, 2021",,,"Dec 30, 2020","Jun 29, 2021",14.61%,9.45%,3.37%,8.00%,8.53B,49.52,,2.78B,1.37B,630M,3.45,,1.86B,10.75,3.12B,36.35,2.49,42.96,1.49B,418.38M,Value,6411 TE,Basic Materials,21173,1,3,"Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, human milk oligosaccharides, and vitamins, as well as premix, market-ready solutions, and personalized nutrition; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty food enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; and Dyneema, a fiber solution for use in ropes and lines, and outdoor and sports applications. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides yeast and enzymes for the conversion of starch, corn fiber, and biomass. Koninklijke DSM N.V. has a strategic partnership with Mile High Labs, LLC to develop and commercialize science-backed cannabinoid consumer products. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.",Heerlen,6,1609372800,1625097600,2,Netherlands,http://www.dsm.com,86400,1,Het Overloon 1,Specialty Chemicals
t-3,KDSKF,3637000000.0,174786000,,,200000000,91000000,182000000,,1961000000,238000000,238000000,1578000000,-21000000,,,,33000000,1961000000,1723000000,0,-38000000,15000000,167000000,180000000,3686000000.0,6858000000.0,7323000000.0,810000000.0,14272000000.0,7323000000.0,1121000000.0,1063000000.0,282000000.0,1686000000.0,2346000000.0,226000000.0,316000000.0,3647000000.0,6305000000.0,352000000.0,40000000.0,1505000000.0,3449000000.0,1953000000.0,1178000000.0,,,,,,615000000,0,493000000,-248000000,-508000000,186000000,15000000,386000000,-26000000,37000000,406000000,403000000,28000000,-94500000,-249000000,-365000000,-124000000,3959000000.0,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,54.737,0.35141885,155.76 - 219.0,-8.503006,-0.03882651,155.76,219.0,1598572800,2.4,61.013622,0.011295787,3.45,6.63,5.12,-0.92795056,210.497 - 213.5,212.4686,0.0,0.0,0,0,finmb_410412,Other OTC,Koninklijke DSM N.V.,EUR,639,214,41.112694,42.963,205.12172,5.3752747,0.026205292,186.0166,24.480392,0.13160327,36793610240,31.749168,4.8994946,15,America/New_York,EDT,-14400000,2,PNK,PRE,us_market,KONINKLIJKE DSM NV,210.497,1630510799,-1.9716034,213.5,213.5,210.497,24294,0.55,,,219.0,155.76,205.12,186.02,639,214,174.79M,,172.26M,0.22%,56.58%,,,,,,2.9,1.34%,2.40,1.13%,,65.50%,"Aug 27, 2020","Aug 04, 2021",,,"Dec 30, 2020","Jun 29, 2021",14.61%,9.45%,3.37%,8.00%,8.53B,49.52,,2.78B,1.37B,630M,3.45,,1.86B,10.75,3.12B,36.35,2.49,42.96,1.49B,418.38M,Value,6411 TE,Basic Materials,21173,1,3,"Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, human milk oligosaccharides, and vitamins, as well as premix, market-ready solutions, and personalized nutrition; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty food enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; and Dyneema, a fiber solution for use in ropes and lines, and outdoor and sports applications. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides yeast and enzymes for the conversion of starch, corn fiber, and biomass. Koninklijke DSM N.V. has a strategic partnership with Mile High Labs, LLC to develop and commercialize science-backed cannabinoid consumer products. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.",Heerlen,6,1609372800,1625097600,2,Netherlands,http://www.dsm.com,86400,1,Het Overloon 1,Specialty Chemicals
